eXoZymes Inc. receives $2.03 million NIH grant for drug discovery.
eXoZymes Inc. received a $2.03 million NIH grant to advance cannabinoid analogs. The funding validates the company's platform amid the rapidly growing minor cannabinoids market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day